FOUNDER & CEO

Francesca Tuazon, Ph.D. founded Science& in 2023 on the idea that the next breakthroughs in STEM will come from diverse, creative, and authentic voices.

During her graduate research, Francesca both saw (and experienced) a gap in immediate and broadly applicable support for scientists from historically excluded groups. At the same time, she was continually struck by the similarities between science and art. A painter since childhood and avid art history enthusiast, she understands the power of creative expression…and saw its potential as a new approach to DEI in STEM.

Francesca combined her experience as a community activist, transformational leader, and bold problem-solver to build a framework of practical skills from the visual, written, and performance arts. Her goal is simple: empower every scientist to express their unique voice.

BOARD OF DIRECTORS

Andre Isaacs is an Associate Professor of Chemistry at the College of the Holy Cross. He teaches courses in organic chemistry and his research group focuses on the synthesis of N-Heterocycles via click chemistry.

He is committed to diversity, equity and inclusion and advocates for scientists with minoritized identities through his visibility on social media, opinion piece and pedagogical publications. As a member of the HHMI Inclusive Excellence team at Holy Cross, he advocates for a change from deficit-minded thinking to an anti-deficit achievement approach to education to improve retention of students from historically excluded groups in STEM.

He currently serves as a member of the Executive Committee of the Division of Organic Chemistry and is a Review Editor for the journal ‘Frontiers in Chemistry’

BOARD OF DIRECTORS

Lorraine Marchand  has three decades of experience in product development, commercialization and digital transformation. She has held leadership positions at IBM, Bristol Myers Squibb, LabCorp, Cognizant, and IQVIA; serves as an advisor to Fortune 500 companies; and has cofounded four companies.

Lorraine serves on the Healthcare and Pharmaceutical Management Program Advisory Board at Columbia Business School and is an adjunct professor of innovation and entrepreneurship at Yeshiva University’s Katz School of Science and Health. She is an investor-member of venture firm Plum Alley and a mentor to the START Program at Princeton University and the New York University Endless Frontier Labs.

She believes that through Science&’s refreshing approach, “innovation will flourish and all of society will benefit.”

BOARD OF DIRECTORS

Lori Goldman is the Founder and Managing Member of Goldman Oak Law, PLLC and has served clients for nearly two decades. A true “businessperson’s lawyer,” Lori excels at guiding her clients through the maze of legal and business decisions to optimize their businesses and realize their goals. She also provides estate planning to enhance lives today and secure futures for tomorrow.

Prior to founding Goldman Oak Law, Lori was the General Counsel and Corporate Secretary of Bryn Mawr Trust. She got her start as a corporate lawyer at Kaye Scholer, LLP (now Arnold Porter Kaye Scholer, LLP) and Stradley Ronon Stevens & Young, LLP.

Lori is excited about the positive impact Science& can have on both a micro and macro level.

ADVISORY BOARD

Jason Diaz, Ph.D., is the Education Program Director at the Wistar Institute. He was previously an Assistant Professor at La Salle University in the Integrated Science, Business, and Technology Program. Jason manages science training programs from the high school level all the way through postdoctoral training.

Jason is passionate about science communication and has been a lifelong lover of blending the arts with the sciences for a richer and more nuanced experience of the world.

He has experienced firsthand the power that comes with inclusive practices and strongly believes in Science&’s mission to ensure that science is for everyone.

ADVISORY BOARD

Richard White, M.D., Ph.D, is a Professor at the University of Oxford and an adjunct faculty member at Memorial Sloan Kettering Cancer Center. His lab is interested in the intersection between developmental biology and cancer biology.

Using both zebrafish and human pluripotent stem cell models of melanoma, his lab has described a mechanism of oncogenic competence, explaining why DNA mutations are only sometimes able to initiate tumors.

He has been awarded the NIH Director’s New Innovator Award, as well as awards from the Melanoma Research Alliance, the Pershing Square Foundation Award, the American Cancer Society, and the Mark Foundation ASPIRE award.